REPAIR Impact Fund由Novo Holdings于2018年成立，总部位于丹麦，目的是为了帮助生物技术初创公司研发抵御抗生素耐药性的疗法。 Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms. |
